
Lynne E Wagoner MD
Adult Congenital Heart Disease, Cardiac Electrophysiology, Heart Failure & Transplantation, Preventive Cardiology
Mercy Heart Institute
Join to view full profile
3000 Mack RdSte 100Fairfield, OH 45014
Phone+1 513-751-4222
Fax+1 513-751-4353
Dr. Wagoner is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Lynne E. Wagoner, MD, is Director of Heart Failure at Mercy Heart Institute in Cincinnati and at Mercy Hospitals in Fairfield, Anderson, and West, all in Ohio. Dr Wagoner received her MD from East Carolina School of Medicine in Greenville, North Carolina. She completed her medical residency and fellowship in cardiology research at Pitt County Memorial Hospital, East Carolina School of Medicine, in Greenville. At the University of Utah Health Sciences Center in Salt Lake City, she completed additional fellowships in cardiology, cardiology transplant and heart failure, and cardiology research. She is board certified in internal medicine, cardiovascular disease, and Advanced Heart Failure and Transplantation. She also has expertise in the treatment and diagnosis of pulmonary arterial hypertension.
Dr Wagoner is a former Associate Professor of Cardiology and Medical Director of Heart Failure and Cardiac Transplantation at the University of Cincinnati.
A fellow of the American College of Cardiology, Dr Wagoner is an active researcher. She has been principal investigator on numerous clinical trials in the fields of heart failure, pulmonary hypertension, and prevention.
Dr Wagoner has authored or coauthored book chapters as well as more than 140 articles, abstracts, and review articles published in peer-reviewed journals such as American Heart Journal, Circulation, and The New England Journal of Medicine.
Education & Training
University of Utah HealthFellowship, Cardiovascular Disease, 1990 - 1994
ECU Health Medical Center/East Carolina UniversityInternship, Internal Medicine, 1986 - 1990
ECU Health Medical Center/East Carolina UniversityResidency, Internal Medicine, 1987 - 1989
Brody School of Medicine at East Carolina UniversityClass of 1986
Certifications & Licensure
OH State Medical License 1994 - 2027
KY State Medical License 1998 - 2007
NC State Medical License 1982 - 2003
UT State Medical License 1990 - 1994
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2014, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2014, 2017
- America's Top Doctors Castle Connolly, 2004-2014
Clinical Trials
- Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT Start of enrollment: 2014 May 31
Publications & Presentations
PubMed
- 129 citationsShort-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload.Marvin A. Konstam, Michael S. Kiernan, Arthur Chandler, Ravi Dhingra, Freny Vaghaiwalla Mody
Journal of the American College of Cardiology. 2017-03-21 - 13 citationsPrognostic impact of the addition of ventilatory efficiency to the Seattle Heart Failure Model in patients with heart failure.Wayne C. Levy, Ross Arena, Lynne E. Wagoner, Todd F. Dardas, William T. Abraham
Journal of Cardiac Failure. 2012-08-01 - 326 citationsValidation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure.Larry A. Allen, G. Michael Felker, Mandeep R. Mehra, Jun R. Chiong, Stephanie H. Dunlap
Journal of Cardiac Failure. 2010-03-01
Grant Support
- Core--Clinical PhysiologyNational Heart, Lung, And Blood Institute2000–2002
- SCOR In Heart FailureNational Center For Research Resources2000–2001
- Cytotoxicity Of Cells Infiltrating Cardiac AllograftsNational Heart, Lung, And Blood Institute1993
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









